Interviews

In Conversation with World Pharma Today at CPHI Milan 2024: Dr. Manuela Schneider-Höfferer, Head of Commercial Development and Strategic Marketing at Lonza, discusses the company's strategic focus, its response to market demands, and the significance of partnerships in the pharmaceutical...

This interview features Mr. Neeraj Sharma, CEO of OneSource Specialty Pharma, a newly established Contract Development and Manufacturing Organization (CDMO) formed by merging three businesses within the Strides Group. With a legacy of over 30 years of Strides Group,...

World Pharma Today's latest interview centers on the groundbreaking partnership between ReciBioPharm and Hongene, focused on advancing gene-editing drug development and manufacturing. The companies share a vision to make high-quality, accessible gene-editing solutions available to patients, driving advancements in life-saving...

The CDMO landscape has shifted dramatically in just the past few years, with the competencies required to lead these organizations evolving to align with changing strategic priorities. In the following conversation, Morten Nielsen and Mindy Steiger of WittKieffer, the...

World Pharma Today, recently got in touch with Roquette’s Dr. Vinod Tuliani, where he spoke extensively about the accolades for the company, the innovations that are taking place in the biopharmaceutical space, and how the company has come of...

In Conversation with Dominic Marasco: AI Beyond Data Crunching for Better Patient Outcomes In this exclusive interview with World Pharma Today, Dominic Marasco, a leader at Envision Pharma Group, delves into the transformative role of artificial intelligence (AI) in the...

In an interview with Nigel Theobald, CEO of N4 Pharma, several key points emerged regarding the company's recent strategic moves and its outlook in the pharmaceutical landscape. 1. Can you provide more insight into the decision to acquire a controlling...